Industry
Biotechnology
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.
Loading...
Open
N/A
Mkt cap
N/A
Volume
N/A
High
N/A
P/E Ratio
N/A
52-wk high
N/A
Low
N/A
Div yield
N/A
52-wk low
N/A
Portfolio Pulse from Benzinga Newsdesk
August 13, 2024 | 12:33 pm
Portfolio Pulse from Benzinga Newsdesk
June 27, 2024 | 1:10 pm
Portfolio Pulse from Benzinga Newsdesk
June 27, 2024 | 12:35 pm
Portfolio Pulse from Benzinga Insights
May 31, 2024 | 4:31 pm
Portfolio Pulse from Benzinga Newsdesk
May 17, 2024 | 12:18 pm
Portfolio Pulse from Benzinga Newsdesk
May 15, 2024 | 3:28 pm
Portfolio Pulse from Benzinga Newsdesk
May 13, 2024 | 12:39 pm
Portfolio Pulse from Benzinga Insights
April 26, 2024 | 12:06 pm
Portfolio Pulse from Benzinga Newsdesk
April 04, 2024 | 10:33 am
Portfolio Pulse from Benzinga Newsdesk
April 03, 2024 | 12:32 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.